Triptans to the rescue: effective therapy for migraine headaches in the workplace.
Bartleson
J D
JD
D000041:Absenteeism; D000328:Adult; D003362:Cost-Benefit Analysis; D004526:Efficiency; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy* / Q000191:economics*; D010080:Oxazoles / Q000627:therapeutic use; D023303:Oxazolidinones; D010880:Piperidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012646:Self Administration; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use; D014363:Tryptamines; D017132:Workplace
D007211:Indoles; D010080:Oxazoles; D023303:Oxazolidinones; D010880:Piperidines; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C089750:zolmitriptan; C093622:rizatriptan; D018170:Sumatriptan; C106783:naratriptan